Form 4: Haemonetics Corp Executive Reports Stock Transactions

Stewart W. Strong, President of Global Hospital at Haemonetics Corp, reports acquisition of shares from performance share units and subsequent disposal for tax obligations.

Summary

• On July 24, 2024, Stewart W. Strong, President, Global Hospital at Haemonetics Corp, acquired 7,110 shares of common stock related to a performance share unit (PSU) award.
• The PSU award was granted on July 13, 2021, and was based on Haemonetics' total shareholder return relative to the S&P MidCap 400 Index from July 13, 2021, to July 12, 2024.
• The Compensation Committee of the Board of Directors certified the performance on July 24, 2024.
• On July 25, 2024, Mr. Strong disposed of 2,798 shares of common stock at a price of $90.58 per share to cover tax obligations related to the vesting of the PSUs.
• Following these transactions, Mr. Strong beneficially owns 22,508 shares of Haemonetics Corp common stock, which includes unvested restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects standard insider trading activity related to compensation and tax obligations, suggesting a neutral to slightly positive sentiment as performance targets were met to trigger the PSU vesting.

Positives

• The vesting of performance share units indicates that Haemonetics Corp met certain performance criteria related to shareholder return relative to the S&P MidCap 400 Index.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, allowing investors to monitor the actions of company executives and directors.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation and tax-related activities.

Key Dates